We propose to continue our program to provide research training in oncology to young surgeons interested in a career in academic surgical oncology. Trainees will be surgical residents with at least 2 years of postgraduate clinical experience. Our T32 Surgical Oncology Research Training Program has supported the research careers of 85 young trainee surgeons over the past 30 years. We are now applying for funding for years 31 to 35. The goals of the 2-year training program are to provide individuals with an intensive research experience in (1) hypothesis formulation, (2) experimental design, (3) data analysis, (4) laboratory/project management, (5) oral and written presentation, and (6) grant writing skills. The ultimate objective of the program is to teach the scientific method and research techniques so that the trainees can perform high-quality independent research on topics ranging the full spectrum of oncology upon completion of their surgical training. This research experience will enable trainees to apply for positions as junior faculty members in academic institutions and become independent clinical and translational researchers. The mentored research will be tailored to the interest and career goals of the trainees and their mentors. Past trainees have worked in a wide variety of disciplines, including tumor immunology, cancer biology, molecular genetics, molecular pathology, and targeted therapeutics. For the proposed cycle, we have added Program Faculty with research programs in cancer outcomes, survivorship, and disparities. The program curriculum is now designed to provide exposure to basic, translational, and population health sciences, as well as clinical surgical oncology, medical oncology, and radiation oncology. Close contact between the trainees, mentors, and program director has been achieved. Trainees are required to attend weekly conferences and didactic lectures at Memorial Sloan Kettering Cancer Center (MSK) that include the fundamentals of research, research presentations, as well as topics in clinical oncology. The scientific quality of research performed by the trainees has been outstanding and most of the fellows have remained in academia. The program continues to be a major commitment of the Department of Surgery at MSK and has benefited from the recent increase in research faculty and research facilities at our institution.

Public Health Relevance

(RELEVANCE) The T32 Surgical Oncology Research Training Program at Memorial Sloan Kettering Cancer Center has supported the research careers of 85 young trainee surgeons over the past 30 years. The ultimate objective of the program is to teach the scientific method and research techniques so that the trainees can perform high- quality independent research in oncology upon completion of their surgical training.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
2T32CA009501-31A1
Application #
9789445
Study Section
Subcommittee I - Transistion to Independence (NCI)
Program Officer
Lim, Susan E
Project Start
1984-09-01
Project End
2024-07-31
Budget Start
2019-08-01
Budget End
2020-07-31
Support Year
31
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Zhang, Jennifer Q; Zeng, Shan; Vitiello, Gerardo A et al. (2018) Macrophages and CD8+ T Cells Mediate the Antitumor Efficacy of Combined CD40 Ligation and Imatinib Therapy in Gastrointestinal Stromal Tumors. Cancer Immunol Res 6:434-447
Brandt, Whitney S; Bouabdallah, Ilies; Tan, Kay See et al. (2018) Factors associated with distant recurrence following R0 lobectomy for pN0 lung adenocarcinoma. J Thorac Cardiovasc Surg 155:1212-1224.e3
Brandt, Whitney S; Yan, Wanpu; Leeman, Jonathan E et al. (2018) Postoperative Radiotherapy for Surgically Resected ypN2 Non-Small Cell Lung Cancer. Ann Thorac Surg 106:848-855
Vitiello, Gerardo A; Medina, Benjamin D; Zeng, Shan et al. (2018) Mitochondrial Inhibition Augments the Efficacy of Imatinib by Resetting the Metabolic Phenotype of Gastrointestinal Stromal Tumor. Clin Cancer Res 24:972-984
Lee, Jun H; Chang, Kevin K; Yoon, Changhwan et al. (2018) Lauren Histologic Type Is the Most Important Factor Associated With Pattern of Recurrence Following Resection of Gastric Adenocarcinoma. Ann Surg 267:105-113
García Nores, Gabriela D; Ly, Catherine L; Savetsky, Ira L et al. (2018) Regulatory T Cells Mediate Local Immunosuppression in Lymphedema. J Invest Dermatol 138:325-335
Ly, Catherine L; Cuzzone, Daniel A; Kataru, Raghu P et al. (2018) Small numbers of CD4+ T cells can induce development of lymphedema. Plast Reconstr Surg :
García Nores, Gabriela D; Ly, Catherine L; Cuzzone, Daniel A et al. (2018) CD4+ T cells are activated in regional lymph nodes and migrate to skin to initiate lymphedema. Nat Commun 9:1970
Brandt, Whitney S; Yan, Wanpu; Zhou, Jian et al. (2018) Outcomes after neoadjuvant or adjuvant chemotherapy for cT2-4N0-1 non-small cell lung cancer: A propensity-matched analysis. J Thorac Cardiovasc Surg :
Gardenier, Jason C; Kataru, Raghu P; Hespe, Geoffrey E et al. (2017) Topical tacrolimus for the treatment of secondary lymphedema. Nat Commun 8:14345

Showing the most recent 10 out of 166 publications